Effects of the Interaction of Rifamycin SV with Serum Albumins on the Resonance Rayleigh Scattering Spectra and Their Analytical Application

In pH 4.5–4.8 Britton‐Robinson buffer solution, rifamycin SV (i.e. rifamycin sodium) can react with serum albumin such as human serum albumin (HSA) and bovine serum albumin (BSA) to form macromolecular complexes by electrostatic attraction and hydrophobic force. As a result, the resonance Rayleigh s...

Full description

Saved in:
Bibliographic Details
Published inChinese journal of chemistry Vol. 26; no. 5; pp. 893 - 897
Main Authors YANG, Ji-Dong, CAO, Tuan-Wu, LIU, Zhong-Fang, KONG, Ling, LIU, Shao-Pu
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 01.05.2008
WILEY‐VCH Verlag
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In pH 4.5–4.8 Britton‐Robinson buffer solution, rifamycin SV (i.e. rifamycin sodium) can react with serum albumin such as human serum albumin (HSA) and bovine serum albumin (BSA) to form macromolecular complexes by electrostatic attraction and hydrophobic force. As a result, the resonance Rayleigh scattering (RRS) of the drug was enhanced remarkably and the RRS peaks were at 374 and 552 nm. The enhancement of RRS (ΔI) is directly proportional to the concentration of HSA or BSA. The linear ranges and the detection limits are 0.03–6.0 µg/mL and 9.0 ng/mL for HSA, and 0.01–8.0 µg/mL and 2.0 ng/mL for BSA, respectively. In this work, a sensitive, selective, simple and fast method for the determination of trace amounts of serum albumin by RRS technique has been developed, which was applied to the determination of serum albumin in the synthesized samples and human urine samples with satisfactory results.
Bibliography:ark:/67375/WNG-3DB9P6XB-X
the National Natural Science Foundation of China - No. 20475045
istex:C44E6B1BDED292081448B0F36B1B3533EED86855
Imbursement Help of Education Committee of Chongqing, China - No. KJ051303
ArticleID:CJOC200890164
ISSN:1001-604X
1614-7065
DOI:10.1002/cjoc.200890164